A spatially heterogeneous network-based metapopulation software model applied to the simulation of a pulmonary tuberculosis infection

Tuberculosis (TB) is an ancient disease that, although curable, still accounts for over 1 million deaths worldwide. Shortening treatment time is an important area of research but is hampered by the lack of models that mimic the full range of human pathology. TB shows distinct localisations during different stages of infection, the reasons for which are poorly understood. Greater understanding of how heterogeneity within the human lung influences disease progression may hold the key to improving treatment efficiency and reducing treatment times.In this work, we present a novel in silico software model which uses a networked metapopulation incorporating both spatial heterogeneity and dissemination possibilities to simulate a TB infection over the whole lung and associated lymphatics. The entire population of bacteria and immune cells is split into a network of patches: members interact within patches and are able to move between them. Patches and edges of the lung network include their own environmental attributes which influence the dynamics of interactions between the members of the subpopulations of the patches and the translocation of members along edges.In this work, we detail the initial findings of a whole-organ model that incorporates distinct spatial heterogeneity features which are not present in standard differential equation approaches to tuberculosis modelling. We show that the inclusion of heterogeneity within the lung landscape when modelling TB disease progression has significant outcomes on the bacterial load present: a greater differential of oxygen, perfusion and ventilation between the apices and the basal regions of the lungs creates micro-environments at the apex that are more preferential for bacteria, due to increased oxygen availability and reduced immune activity, leading to a greater overall bacterial load present once latency is established.These findings suggest that further whole-organ modelling incorporating more sophisticated heterogeneities within the environment and complex lung topologies will provide more insight into the environments in which TB bacteria persist and thus help develop new treatments which are factored towards these environmental conditions.

[1]  N. Pedersen,et al.  The persistence of a SIS disease in a metapopulation , 1999 .

[2]  V. Houk,et al.  The eradication of tuberculosis infection by isoniazid chemoprophylaxis. , 1968, Archives of environmental health.

[3]  Mark A. J. Chaplain,et al.  Modelling the effects of bacterial cell state and spatial location on tuberculosis treatment: Insights from a hybrid multiscale cellular automaton model , 2016, bioRxiv.

[4]  Roslyn I. Hickson,et al.  A Metapopulation Model of Tuberculosis Transmission with a Case Study from High to Low Burden Areas , 2012, PloS one.

[5]  Dirk Helbing,et al.  Saving Human Lives: What Complexity Science and Information Systems can Contribute , 2014, Journal of statistical physics.

[6]  Matthew D. Zimmerman,et al.  The association between sterilizing activity and drug distribution into tuberculosis lesions , 2015, Nature Medicine.

[7]  D. Smith,et al.  Pathogenesis of tuberculosis: pathway to apical localization. , 1994, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[8]  L. Schlesinger,et al.  Mini Review Article , 2022 .

[9]  Vincent O. Baron,et al.  Defining dormancy in mycobacterial disease. , 2016, Tuberculosis.

[10]  P. Karakousis,et al.  Latent Tuberculosis Infection: Myths, Models, and Molecular Mechanisms , 2014, Microbiology and Molecular Reviews.

[11]  J. Arino,et al.  Disease Spread in Metapopulations , 2005 .

[12]  D. Kirschner,et al.  A methodology for performing global uncertainty and sensitivity analysis in systems biology. , 2008, Journal of theoretical biology.

[13]  J. Pieters,et al.  Mycobacterium tuberculosis and the macrophage: maintaining a balance. , 2008, Cell host & microbe.

[14]  James E Gomez,et al.  M. tuberculosis persistence, latency, and drug tolerance. , 2004, Tuberculosis.

[15]  R. Levins Some Demographic and Genetic Consequences of Environmental Heterogeneity for Biological Control , 1969 .

[16]  P. Kaye,et al.  Alveolar Macrophages Transport Pathogens to Lung Draining Lymph Nodes1 , 2009, The Journal of Immunology.

[17]  J. Friedland,et al.  Permutations of time and place in tuberculosis. , 2015, The Lancet. Infectious diseases.

[18]  Denise Kirschner,et al.  A Model to Predict Cell-Mediated Immune Regulatory Mechanisms During Human Infection with Mycobacterium tuberculosis1 , 2001, The Journal of Immunology.

[19]  Denise Kirschner,et al.  A review of computational and mathematical modeling contributions to our understanding of Mycobacterium tuberculosis within-host infection and treatment. , 2017, Current opinion in systems biology.

[20]  Denise E. Kirschner,et al.  Multi-Scale Modeling Predicts a Balance of Tumor Necrosis Factor-α and Interleukin-10 Controls the Granuloma Environment during Mycobacterium tuberculosis Infection , 2013, PloS one.

[21]  R. Z. Topić Latent tuberculosis infection , 2012 .

[22]  Simeone Marino,et al.  TNF and IL-10 are major factors in modulation of the phagocytic cell environment in lung and lymph node in tuberculosis: a next-generation two-compartmental model. , 2010, Journal of theoretical biology.

[23]  Dawei Zhao,et al.  Statistical physics of vaccination , 2016, ArXiv.

[24]  D. Gillespie A General Method for Numerically Simulating the Stochastic Time Evolution of Coupled Chemical Reactions , 1976 .

[25]  O. Bjørnstad,et al.  Chapter 17 , 2019 .

[26]  R. D. Des Prez,et al.  Apical localization of pulmonary tuberculosis, chronic pulmonary histoplasmosis, and progressive massive fibrosis of the lung. , 1983, Chest.

[27]  Mathieu Génois,et al.  Temporal Gillespie Algorithm: Fast Simulation of Contagion Processes on Time-Varying Networks , 2015, PLoS Comput. Biol..

[28]  M. Gilpin,et al.  Metapopulation dynamics: a brief his-tory and conceptual domain , 1991 .

[29]  I. Humphreys,et al.  A role for dendritic cells in the dissemination of mycobacterial infection. , 2006, Microbes and infection.

[30]  David Gammack,et al.  A metapopulation model of granuloma formation in the lung during infection with mycobacterium tuberculosis. , 2005, Mathematical biosciences and engineering : MBE.

[31]  Philippe Bousso,et al.  T-cell activation by dendritic cells in the lymph node: lessons from the movies , 2008, Nature Reviews Immunology.

[32]  Jose L. Segovia-Juarez,et al.  Identifying control mechanisms of granuloma formation during M. tuberculosis infection using an agent-based model. , 2004, Journal of theoretical biology.

[33]  Vincent O. Baron,et al.  Phenotypic resistance in mycobacteria: is it because I am old or fat that I resist you? , 2015, The Journal of antimicrobial chemotherapy.

[34]  R. Hunter Tuberculosis as a three-act play: A new paradigm for the pathogenesis of pulmonary tuberculosis. , 2016, Tuberculosis.

[35]  R. Hunter,et al.  Pathogenesis of post primary tuberculosis: immunity and hypersensitivity in the development of cavities. , 2014, Annals of clinical and laboratory science.

[36]  J. Murray Bill Dock and the location of pulmonary tuberculosis: how bed rest might have helped consumption. , 2003, American journal of respiratory and critical care medicine.

[37]  S. Gillespie,et al.  Evolution of Drug Resistance in Mycobacterium tuberculosis: Clinical and Molecular Perspective , 2002, Antimicrobial Agents and Chemotherapy.

[38]  M. Behr,et al.  Is tuberculosis a lymphatic disease with a pulmonary portal? , 2014, The Lancet. Infectious diseases.

[39]  D. Kirschner,et al.  The human immune response to Mycobacterium tuberculosis in lung and lymph node. , 2004, Journal of theoretical biology.

[40]  S. Ehlers Lazy, Dynamic or Minimally Recrudescent? On the Elusive Nature and Location of the Mycobacterium Responsible for Latent Tuberculosis , 2009, Infection.

[41]  A. Mihret,et al.  The role of dendritic cells in Mycobacterium tuberculosis infection , 2012, Virulence.

[42]  U. V. von Andrian,et al.  Mechanisms and consequences of dendritic cell migration. , 2008, Immunity.

[43]  A. Crook,et al.  Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis. , 2014, The New England journal of medicine.

[44]  S. Kaufmann,et al.  The many faces of host responses to tuberculosis , 2001, Immunology.

[45]  Roger Stevens,et al.  Gray's Anatomy for Students. , 2015 .